TP53 gene mutations in Hodgkin lymphoma are infrequent and not associated with absence of Epstein-Barr virus

International Journal of Cancer

Volumn 94, Issue 1, 2001, Pages 60-66

  Maggio, Ewerton M ^a   Stekelenburg, Eva ^a   Van Berg, Anke Den ^a   Poppema, Sibrand ^a,b  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b NONE   (Netherlands)

Author keywords

EBV; Hodgkin lymphoma; IgH; p53

Indexed keywords

DNA; MESSENGER RNA; PROTEIN P53;

APOPTOSIS; ARTICLE; CORRELATION FUNCTION; DNA DETERMINATION; EPSTEIN BARR VIRUS; GENE AMPLIFICATION; GENE MUTATION; HODGKIN DISEASE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; PRIORITY JOURNAL; PROTEIN EXPRESSION; REED STERNBERG CELL;

GENE REARRANGEMENT; GENES, P53; HERPESVIRUS 4, HUMAN; HODGKIN DISEASE; IMMUNOGLOBULIN HEAVY CHAINS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MUTATION; POLYMERASE CHAIN REACTION; RNA, VIRAL; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0035479946     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/ijc.1438     Document Type: Article

References (34)

1. The origin of Hodgkin and Reed Sternberg cells in Hodgkin's disease
2. Hodgkin and Reed-Sternberg cells represent an expansion of a single clone originating from a germinal center B-cell with functional immunoglobulin gene rearrangements but defective immunoglobulin transcription
3. Overexpression of p53 in Hodgkin's disease: Lack of correlation with Epstein-Barr virus infection
4. Oncogene expression in tumour cells of pediatric Hodgkin's disease in Argentina - Correlation with Epstein Barr virus presence
5. Induction of bc1-2 expression by Epstein-Barr virus latent membrane protein-1 protects infected B cells from programmed cell death
6. The Epstein-Barr virus LMP1 amino acid sequence that engages tumor necrosis factor receptor associated factors is critical for primary B lymphocyte growth transformation
7. Expression of Epstein-Barr virus nuclear antigen-1 induces B cell neoplasia in transgenic mice
8. Expression of Epstein-Barr virus nuclear antigen 1 is associated with enhanced expression of CD25 in the Hodgkin cell line L428
9. Epstein-Barr virus in Hodgkin's disease
10. Immune reactions in classical HL
11. Clonal deleterious mutations in the IκBα gene in the malignant cells in HL
12. Overexpression of I kappa B Alpha without inhibition of NF-κB activity and mutations in the I kappa B alpha gene in Reed-Sternberg cells
13. p53 mutations in Hodgkin's disease
14. p53 expression in Reed-Sternberg cells does not correlate with gene mutations in Hodgkin's disease
15. Tumor suppressor p53: Regulation and function
16. The Reed-Sternberg cells of Hodgkin disease are clonal
17. PCR-mismatch analysis of p53 gene mutation in Hodgkin's disease
18. Mutation of p53 in primary biopsy material and cell lines from Hodgkin disease
19. Single cell analysis of Hodgkin and Reed Sternberg cells: Molecular heterogeneity of gene expression and p53 mutations
20. Mutation of the p53 gene is not a typical feature of Hodgkin and Reed-Sternberg cells in Hodgkin's disease
21. MDM2 gene amplification and lack of p53 point mutations in Hodgkin and Reed-Sternberg cells: Results from single-cell polymerase chain reaction and molecular cytogenetic studies
22. Characteristics of Hodgkin's disease derived cell lines
23. Molecular single cell analysis demonstrates the derivation of a peripheral blood derived cell line (L1236) from the Hodgkin/Reed-Sternberg cells of a HL patient
24. Morphologic, immunologic, enzyme histochemical and chromosomal analysis of a cell line derived from Hodgkin's disease. Evidence for a B-cell origin of Reed-Sternberg cells
25. Laser-capture microdissection: Opening the microscopic frontier to molecular analysis
26. Comprehensive TP53-denaturing gradient gel electrophoresis mutation detection assay also applicable to archival paraffin-embedded tissue
27. Molecular single cell studies of normal and transformed lymphocytes
28. Rare occurrence of classical Hodgkin's disease as a T cell lymphoma
29. EBNA-5, an Epstein Barr virus-encoded nuclear antigen, binds to the retinoblastoma and p53 proteins
30. Epstein-Barr virus and Hodgkin's disease: Transcriptional analysis of virus latency in the malignant cells
31. Purification and biochemical characterization of the Epstein-Barr virus-determined nuclear antigen and an associated protein with a 53,000-dalton subunit
32. Epstein-Barr virus EBNA-LP and transcription regulation properties of pRB, p107 and p53 in transfection assay
33. Epstein-Barr virus efficiently immortalizes human B cells without neutralizing the function of p53
34. Expression of p53 and mdm-2 proteins in Hodgkin's disease. Absence of correlation with the presence of Epstein-Bar virus